Stockscreener 앱 받기
5.76
4.35%
0.24
시간 외 거래:
5.76
전일 마감가:
$5.52
열려 있는:
$5.53
하루 거래량:
13,656
Relative Volume:
0.51
시가총액:
$9.47M
수익:
$770.00K
순이익/손실:
$-38.84M
주가수익비율:
-0.4055
EPS:
-14.2049
순현금흐름:
$-43.02M
1주 성능:
-9.57%
1개월 성능:
-11.74%
6개월 성능:
-3.03%
1년 성능:
-58.09%
1일 변동 폭
$5.53
$5.85
1주일 범위
$5.52
$6.43
52주 변동 폭
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
명칭
Lyra Therapeutics Inc
전화
617-373-4600
주소
480 ARSENAL WAY, WATERTOWN, MA
LYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
5.76 | 9.08M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-05-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | 재개 | BTIG Research | Buy |
| 2023-08-31 | 개시 | H.C. Wainwright | Buy |
| 2022-05-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-26 | 개시 | BTIG Research | Buy |
| 2020-05-26 | 개시 | BofA/Merrill | Buy |
| 2020-05-26 | 개시 | Jefferies | Buy |
| 2020-05-26 | 개시 | William Blair | Outperform |
모두보기
Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스
What indicators show strength in Lyra Therapeutics Inc.Weekly Profit Recap & Accurate Intraday Trade Tips - newser.com
Will Lyra Therapeutics Inc. stock see insider buyingTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Is Lyra Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Risk adjusted return profile for Lyra Therapeutics Inc. analyzedWeekly Market Outlook & High Accuracy Buy Signal Tips - newser.com
What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Is Lyra Therapeutics Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
How Lyra Therapeutics Inc. stock benefits from global expansionJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
Identifying reversal signals in Lyra Therapeutics Inc.July 2025 Retail & Advanced Technical Signal Analysis - newser.com
Is Lyra Therapeutics Inc. still worth holding after the dipRate Hike & Low Drawdown Investment Strategies - newser.com
Will Lyra Therapeutics Inc. outperform the marketJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
Why Lyra Therapeutics Inc. stock could see breakout soonGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Price momentum metrics for Lyra Therapeutics Inc. explainedJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com
Is Lyra Therapeutics Inc. stock a bargain at current levelsFed Meeting & Daily Risk Controlled Trade Plans - newser.com
Published on: 2025-10-29 21:52:23 - newser.com
Will earnings trigger a reversal in Lyra Therapeutics Inc.2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Order flow analysis tools used on Lyra Therapeutics Inc.Portfolio Value Report & Risk Adjusted Swing Trade Ideas - newser.com
How Lyra Therapeutics Inc. stock responds to policy changesPortfolio Performance Summary & Daily Stock Trend Watchlist - Fundação Cultural do Pará
Aug Selloffs: Is Lyra Therapeutics Inc. stock a bargain at current levelsJuly 2025 Volume & AI Driven Stock Price Forecasts - Fundação Cultural do Pará
How buybacks impact Lyra Therapeutics Inc. stock valuePortfolio Value Report & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará
Published on: 2025-10-27 05:33:04 - newser.com
Lyra Therapeutics Stock Fell 11% in a Week, What Now? - Trefis
Lyra Therapeutics Inc (LYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):